 | Cl-amidine (TFA) | IC50 | 3400.0 [1], 4000.0 [2], 9000.0 [3], 15000.0 [4] |
 | Cl-amidine (TFA) | Ki | 180000.0 [1] |
 | F-Amidine | IC50 | 15000.0 [1], 21000.0 [2], 51000.0 [3], 530000.0 [4] |
 | F-Amidine | Ki | 330000.0 [1] |
 | 2-{[(2s)-1-Amino-5-{[(1z)-2-Fluoroethanimidoyl]amino}-1-Oxopentan-2-Yl]carbamoyl}benzoic Acid | IC50 | 400.0 [1], 1100.0 [2], 4600.0 [3], 32000.0 [4] |
 | 2-{[(2s)-1-Amino-5-{[(1z)-2-Fluoroethanimidoyl]amino}-1-Oxopentan-2-Yl]carbamoyl}benzoic Acid | Ki | 16000.0 [1] |
 | 2-{[(2s)-1-Amino-5-{[(1z)-2-Chloroethanimidoyl]amino}-1-Oxopentan-2-Yl]carbamoyl}benzoic Acid | IC50 | 1100.0 [1], 2400.0 [2], 5300.0 [3], 22000.0 [4] |
 | 2-{[(2s)-1-Amino-5-{[(1z)-2-Chloroethanimidoyl]amino}-1-Oxopentan-2-Yl]carbamoyl}benzoic Acid | Ki | 13000.0 [1] |
 | Minocycline | IC50 | 620000.0 [1] |
 | Minocycline | Ki | 180000.0 [1], 540000.0 [2] |
 | Chlortetracycline | IC50 | 100000.0 [1] |
 | Chlortetracycline | Ki | 110000.0 [1], 540000.0 [2] |
 | Streptomycin | IC50 | 1800000.0 [1] |
 | Streptomycin | Ki | 560000.0 [1] |
 | Doxycycline | IC50 | 860000.0 [1] |
 | Doxycycline | Ki | 630000.0 [1] |
 | Methotrexate | IC50 | 10000000.0 [1] |
 | Tetracycline | IC50 | 780000.0 [1] |
 | Azathioprine | IC50 | 8100000.0 [1] |
 | Clindamycin | IC50 | 5100000.0 [1] |
 | Azithromycin | IC50 | 10000000.0 [1] |
 | Trimethoprim | IC50 | 7500000.0 [1] |
 | Sulfamethoxazole | IC50 | 10000000.0 [1] |
 | Mesalamine | IC50 | 10000000.0 [1] |
 | Leflunomide | IC50 | 2400000.0 [1] |
 | Sulfapyridine | IC50 | 10000000.0 [1] |
 | Streptonigrin | IC50 | 2500.0 [1] |
 | Cl-amidine | IC50 | 5900.0 [1] |
 | 7-Amino-2-pyridin-2-ylquinoline-5,8-dione | IC50 | 640.0 [1] |
 | 7-Bromo-6-methoxyquinoline-5,8-dione | IC50 | 3300.0 [1] |
 | 6-(7-Amino-5,8-dioxo-5,8-dihydroquinolin-2-yl)picolinic acid | IC50 | 240.0 [1] |
 | 7-Aminoquinoline-5,8-dione | IC50 | 1000.0 [1] |
 | 5,5-Dimethyl-3-(piperazin-1-ylmethyl)imidazolidine-2,4-dione | Ki | 183000.0 [1] |
 | [(3S,4R)-3-Amino-4-hydroxypiperidin-1-yl]-[7-methoxy-1-methyl-2-[1-(2,2,2-trifluoroethyl)indol-2-yl]benzimidazol-5-yl]methanone | IC50 | 79.43 [1] |
 | [(3R)-3-Aminopiperidin-1-yl]-[2-(1-ethylindol-2-yl)-7-methoxy-1-methylbenzimidazol-5-yl]methanone | IC50 | 100.0 [1] |
 | [(3R)-3-Aminopiperidin-1-yl]-[7-methoxy-1-methyl-2-[1-(2,2,2-trifluoroethyl)indol-2-yl]benzimidazol-5-yl]methanone | IC50 | 50.12 [1] |
 | [(3R)-3-Aminopiperidin-1-yl]-[2-[1-(cyclopropylmethyl)indol-2-yl]-7-methoxy-1-methylbenzimidazol-5-yl]methanone | IC50 | 39.81 [1] |
 | [(3R)-3-Aminopiperidin-1-yl]-[1-methyl-2-[1-(2,2,2-trifluoroethyl)indol-2-yl]benzimidazol-5-yl]methanone | IC50 | 158.49 [1] |
 | [(3R)-3-Aminopiperidin-1-yl]-[2-[1-(cyclopropylmethyl)indol-2-yl]-1-methylbenzimidazol-5-yl]methanone | IC50 | 125.89 [1] |
 | N-[(2S)-4-(4-Methylpiperazin-1-yl)-1-oxo-1-(propan-2-ylamino)butan-2-yl]furan-2-carboxamide | Ki | 488000.0 [1] |
 | N-[(2S)-1-(Benzylamino)-1-oxo-4-(triazol-1-yl)butan-2-yl]furan-2-carboxamide | Ki | 2823000.0 [1] |
 | N-[(2S)-4-(4-Methylpiperazin-1-yl)-1-oxo-1-(propan-2-ylamino)butan-2-yl]cyclohexanecarboxamide | Ki | 10000000.0 [1] |
 | N-[(2S)-1-(Benzylamino)-4-imidazol-1-yl-1-oxobutan-2-yl]furan-2-carboxamide | Ki | 10000000.0 [1] |
 | N-[(2S)-4-(4-Methylpiperazin-1-yl)-1-oxo-1-(propan-2-ylamino)butan-2-yl]morpholine-4-carboxamide | Ki | 10000000.0 [1] |
 | N-[(2S)-1-(Benzylamino)-4-imidazol-1-yl-1-oxobutan-2-yl]-1-methylpyrrole-2-carboxamide | Ki | 180000.0 [1] |
 | N-[(2S)-4-[4-(Cyanomethyl)imidazol-1-yl]-1-oxo-1-(propan-2-ylamino)butan-2-yl]furan-2-carboxamide | Ki | 591000.0 [1] |
 | 5,5-Dimethyl-3-[2-(2H-tetrazol-5-yl)ethyl]imidazolidine-2,4-dione | Ki | 47000.0 [1] |
 | N-[(2S)-1-(Benzylamino)-1-oxo-4-(triazol-1-yl)butan-2-yl]-1-methylpyrrole-2-carboxamide | Ki | 64000.0 [1] |
 | N-[(2S)-4-Imidazol-1-yl-1-oxo-1-(propan-2-ylamino)butan-2-yl]furan-2-carboxamide | Ki | 88000.0 [1] |
 | N'-[3-(1-Benzylindol-3-yl)propyl]-2-chloroethanimidamide | IC50 | 29000.0 [1] |
 | 2-Chloro-N'-[3-[1-(cyclopentylmethyl)indazol-3-yl]propyl]ethanimidamide | IC50 | 16000.0 [1] |
 | 2-Chloro-N'-[3-[1-(cyclopentylmethyl)indol-3-yl]propyl]ethanimidamide | IC50 | 21000.0 [1] |
 | 2-Chloro-N'-[3-(1-methylindol-3-yl)propyl]ethanimidamide | IC50 | 190000.0 [1] |
 | 2-Chloro-N'-[3-(1-ethylindol-3-yl)propyl]ethanimidamide | IC50 | 36000.0 [1] |
 | 5,5-Dimethyl-3-(2-morpholin-4-ylethyl)imidazolidine-2,4-dione | Ki | 1430000.0 [1] |
 | 2-Fluoroacetimidamide hydrochloride | IC50 | 10000000.0 [1] |
 | 5,5-Dimethyl-3-(2-pyrrolidin-1-ylethyl)imidazolidine-2,4-dione | Ki | 4643000.0 [1] |
 | 3-(2-Imidazol-1-ylethyl)-5,5-dimethylimidazolidine-2,4-dione | Ki | 632000.0 [1] |
 | 7-Amino-6-bromoquinoline-5,8-dione | IC50 | 560.0 [1] |
 | (2S)-5-[(1-Amino-2-fluoroethylidene)amino]-2-(benzenesulfonamido)pentanamide | IC50 | 500000.0 [1] |
 | N-[(2S)-1-Amino-5-[(1-amino-2-fluoroethylidene)amino]-1-oxopentan-2-yl]-1H-imidazole-5-carboxamide | IC50 | 230000.0 [1] |
 | N-[(2S)-1-Amino-5-[(1-amino-2-fluoroethylidene)amino]-1-oxopentan-2-yl]-1H-pyrrole-3-carboxamide | IC50 | 19000.0 [1] |
 | N-[(2S)-1-Amino-5-[(1-amino-2-fluoroethylidene)amino]-1-oxopentan-2-yl]-2-hydroxy-5-nitrobenzamide | IC50 | 12000.0 [1] |
 | 2-Fluoro-N'-propylethanimidamide | IC50 | 1000000.0 [1] |
 | N'-Benzyl-2-fluoroethanimidamide | IC50 | 1000000.0 [1] |
 | 2-Fluoro-N'-phenylethanimidamide | IC50 | 500000.0 [1] |
 | N-[(2S)-1-Amino-3-[3-[(1-amino-2-fluoroethylidene)amino]phenyl]-1-oxopropan-2-yl]benzamide | IC50 | 310000.0 [1] |
 | N-[(1S)-2-Amino-1-[3-[(1-amino-2-fluoroethylidene)amino]phenyl]-2-oxoethyl]benzamide | IC50 | 2100000.0 [1] |
 | N-[(2S)-1-Amino-3-[4-[(1-amino-2-fluoroethylidene)amino]phenyl]-1-oxopropan-2-yl]benzamide | IC50 | 310000.0 [1] |
 | N-[(2S)-1-Amino-3-[4-[[(1-amino-2-fluoroethylidene)amino]methyl]phenyl]-1-oxopropan-2-yl]benzamide | IC50 | 1000000.0 [1] |
 | N-[4-[(1-Amino-2-fluoroethylidene)amino]butyl]benzamide | IC50 | 1000000.0 [1] |
 | N'-[4-(Benzenesulfonamido)butyl]-2-fluoroethanimidamide | IC50 | 1000000.0 [1] |